Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,039.36
-6.3090-0.31%
Number of Gainers:254
Number of Losers:747
Number of Flat:18
PE:- -
High:2,045.70
Open:2,045.70
Low:2,029.74
Close:2,045.67
Volume:5.18B
Turnover:619.26B
Market Cap:97.41T
Float Cap:91.17T

Loading ...

Intel Corp. Stock Sheds 3.4%, Underperforms Peers

Dow Jones
·
Sep 26

IEMG ETF Gains 1.0%

Dow Jones
·
Sep 26

GLD ETF Climbs 0.4%

Dow Jones
·
Sep 26

AGG ETF Gains 0.2%

Dow Jones
·
Sep 26

BNDX ETF Climbs 0.1%

Dow Jones
·
Sep 26

Microsoft Corp. Stock Advances 3.7%, Outperforms Peers

Dow Jones
·
Sep 26

Manulife Financial Corp. Stock Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

Super Micro Computer Inc. Stock Rallies 4.2%, Outperforms Peers

Dow Jones
·
Sep 26

Nutrien Ltd. Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

Texas Instruments Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

PayPal Holdings Inc. Stock Rises 4.6%, Outperforms Peers

Dow Jones
·
Sep 26

Gartner Inc. Stock Rises 4.8%, Outperforms Peers

Dow Jones
·
Sep 26

CrowdStrike Holdings Inc. Cl a Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

Pool Corporation Announces Director Appointment

THOMSON REUTERS
·
Sep 26

Enbridge Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

OpenAI Works to Understand Full Scope of Agent Activity as User Data Leak Emerges

Reuters
·
Sep 26

Moderately bullish activity in American Airlines with shares up 3.9%

TIPRANKS
·
Sep 26

Merck & Co - Daiichi Sankyo and Merck Withdraw Bla for Ifinatamab Deruxtecan in Es-Sclc in U.S.

THOMSON REUTERS
·
Sep 26

Merck & Co - Withdrawal Based on FDA Discussions; Phase 2 Data Do not Satisfy Approval Requirements

THOMSON REUTERS
·
Sep 26

Merck & Co - Patient Enrollment Continues in Ideate-Lung02 Phase 3 Trial for Ifinatamab Deruxtecan

THOMSON REUTERS
·
Sep 26